XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

75,411 resources

By Version

R2: 0
R2B: 0
R3: 3,448
R4: 55,341
R4B: 3,134
R5: 13,264
R6: 224

By Authority

none: 25,640
hl7: 42,405
ihe: 1,382
national: 3,470
who: 2,514

By Realm

none: 22,398
au: 648
be: 387
br: 299
ca: 764
ch: 1,527
cl: 469
cr: 45
cz: 384
de: 2,066
dk: 1,474
ee: 276
eu: 1,253
fi: 87
fr: 1,545
il: 308
in: 163
it: 181
jp: 293
kr: 5
nl: 2,153
no: 26
nz: 79
pl: 83
se: 29
sl: 2
stt: 116
tw: 901
uk: 97
us: 19,481
uv: 17,592
vn: 107
other: 7

Start Prev Rows 52800 - 53000 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1215	Hepatitis A Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1216	Hepatitis B Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1218	Child Influenza Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219	Inactivated Polio Vaccine (IPV)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1221	Pneumococcal Conjugate Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1223	Rotavirus Vaccine (3 dose schedule)	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1224	Measles, Mumps and Rubella (MMR) Vaccine	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1265	Aromatase Inhibitors	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1266	Glucocorticoids (oral only)	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480	Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1481	Potentially Harmful Antiinfectives for Older Adults	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1510	Dementia Medications	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1522	Potentially Harmful Benzodiazepines for Older Adults	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.196.12.1523	Potentially Harmful Antipsychotics for Older Adults	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1005	Bilateral Mastectomy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1009	Primary THA Procedure	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1015	Flexible Sigmoidoscopy	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1016	Flexible Sigmoidoscopy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1017	Flexible Sigmoidoscopy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1020	Fecal Occult Blood Test (FOBT)	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1023	Group A Streptococcus Test	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1024	HbA1c Laboratory Test	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1026	Hysterectomy with No Residual Cervix	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1027	Hysterectomy with No Residual Cervix	active	2024-11	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1035	Total Colectomy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1036	Total Colectomy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1055	XRay Study	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1061	Gastric Bypass Surgery	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1062	Gastric Bypass Surgery	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1080	Primary THA Procedure	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1084	History of bilateral mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1085	History of bilateral mastectomy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1086	Status Post Left Mastectomy	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1087	Status Post Right Mastectomy	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1089	Unilateral Mastectomy, Unspecified Laterality	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1090	Unilateral Mastectomy, Unspecified Laterality	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1091	Status Post Left Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1092	Status Post Right Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1096	Major Transplant	active	2021-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1097	Major Transplant	active	2021-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1132	Unilateral Mastectomy Left	active	2021-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1133	Unilateral Mastectomy Right	active	2021-10	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1134	Hysterectomy with No Residual Cervix	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1135	Hysterectomy with No Residual Cervix	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1140	Bilateral Mastectomy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1143	Total Colectomy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1144	Unilateral Mastectomy Left	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1145	Unilateral Mastectomy Right	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.11.1148	Palliative Intervention	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1005	Bilateral Mastectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1006	Primary THA Procedure	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1010	Flexible Sigmoidoscopy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1011	Fecal Occult Blood Test (FOBT)	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1012	Group A Streptococcus Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1013	HbA1c Laboratory Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1014	Hysterectomy with No Residual Cervix	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1019	Total Colectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1034	XRay Study	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1050	Gastric Bypass Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1068	History of bilateral mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1069	Status Post Left Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1070	Status Post Right Mastectomy	active	2017-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1071	Unilateral Mastectomy, Unspecified Laterality	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1075	Major Transplant	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1133	Unilateral Mastectomy Left	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1134	Unilateral Mastectomy Right	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.198.12.1135	Palliative Care Intervention	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1064	Anaphylactic Reaction to DTaP Vaccine	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1100	Malabsorption Syndromes	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1102	Malabsorption Syndromes	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1105	Intussusception	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1106	Intussusception	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1107	Influenza Virus LAIV Vaccine	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.11.1108	Influenza Virus LAIV Vaccine Administered	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1031	Anaphylactic Reaction to DTaP Vaccine	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1050	Malabsorption Syndromes	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.199.12.1056	Intussusception	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2446	Lower Extremity Visual Inspection Test	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2447	Pedal Pulse Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2448	Monofilament Test Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2449	Monofilament Tests	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2450	Lower Extremity Neurological Assessment Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2451	Lower Extremity Neurological Tests	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2452	Lower Extremity Visual Inspection Result or Finding	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1004.2616	Autonomous Eye Exam Result or Finding	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.1577	Pharmacologic Therapy for Hypertension	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1036	Chronic Kidney Disease, Stage 5	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1037	Chronic Kidney Disease, Stage 5	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1049	Patient Provider Interaction	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1058	Psych Visit for Family Psychotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1063	Occupational Therapy Evaluation	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1067	Dementia and Mental Degenerations	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1068	Dementia and Mental Degenerations	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1069	Standardized Tools for Assessment of Cognition	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1071	Radiation Treatment Management	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1072	Radiation Treatment Management	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1073	Standardized Pain Assessment Tool	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1078	Cancer	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1079	Cancer	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1080	Chemotherapy Administration	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1081	Chemotherapy Administration	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.111	Ophthalmological Services	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.113	Prostate Cancer Treatment	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.118	Initial Myocardial Infarction	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.119	Initial Myocardial Infarction	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.120	Coronary Artery Disease No MI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1238	Ejection Fraction	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1243	Psychoanalysis	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1244	Renal Failure Due to ACE Inhibitor	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1251	Group Psychotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1256	Allergy to ACE Inhibitor or ARB	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1257	Intolerance to ACE Inhibitor or ARB	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.133	Beta Blocker Therapy	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1333	Allergy to Beta Blocker Therapy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1334	Intolerance to Beta Blocker Therapy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1341	Heart Rate	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1342	Beta Blocker Therapy for LVSD	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1344	Acute and Subacute Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1353	Limited Life Expectancy	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1363	Annual Wellness Visit	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1364	Macular Exam	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1372	Tobacco Use Screening	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1374	Bone Scan	active	2018-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1377	Level of Severity of Retinopathy Findings	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1381	Macular Edema Findings Present	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1401	Cognitive Assessment	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1402	Cup to Disc Ratio	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1403	Optic Disc Exam for Structural Abnormalities	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1509	Acute and Subacute Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1521	Burn Confined to Eye and Adnexa	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1523	Burn Confined to Eye and Adnexa	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1524	Cataract Secondary to Ocular Disorders	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1526	Cataract Secondary to Ocular Disorders	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1527	Cataract Surgery	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1528	Cataract Surgery	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1529	Cataract Congenital	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1530	Cataract Congenital	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1532	Cataract Mature or Hypermature	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1534	Cataract Mature or Hypermature	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1535	Cataract Posterior Polar	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1537	Cataract Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1538	Certain Types of Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1540	Certain Types of Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1542	Chronic Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1543	Chronic Iridocyclitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1544	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1546	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1548	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1549	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1550	Disorders of Cornea Including Corneal Opacity	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1552	Disorders of Cornea Including Corneal Opacity	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1561	Glaucoma	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1562	Glaucoma	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1564	Hereditary Corneal Dystrophies	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1566	Hereditary Corneal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1571	Hypotony of Eye	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1572	Hypotony of Eye	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1574	Injury to Optic Nerve and Pathways	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1575	Injury to Optic Nerve and Pathways	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1577	Central Corneal Ulcer	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1578	Central Corneal Ulcer	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1582	Open Wound of Eyeball	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1583	Open Wound of Eyeball	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1587	Pathologic Myopia	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1588	Pathologic Myopia	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1590	Posterior Lenticonus	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1591	Posterior Lenticonus	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1601	Retrolental Fibroplasias	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1603	Retrolental Fibroplasias	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1612	Traumatic Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1613	Traumatic Cataract	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1615	Uveitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1617	Uveitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1618	Vascular Disorders of Iris and Ciliary Body	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1620	Vascular Disorders of Iris and Ciliary Body	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1621	Visual Field Defects	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1623	Visual Field Defects	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1626	Amblyopia	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1628	Amblyopia	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1632	Choroidal Degenerations	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1634	Choroidal Degenerations	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1635	Choroidal Detachment	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1637	Choroidal Detachment	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1638	Choroidal Hemorrhage and Rupture	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1640	Choroidal Hemorrhage and Rupture	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1641	Degeneration of Macula and Posterior Pole	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1643	Degeneration of Macula and Posterior Pole	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1644	Degenerative Disorders of Globe	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1646	Degenerative Disorders of Globe	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1647	Diabetic Macular Edema	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1649	Diabetic Macular Edema	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1653	Disorders of Optic Chiasm	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1655	Disorders of Optic Chiasm	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1656	Disorders of Visual Cortex	active	2021-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1658	Disorders of Visual Cortex	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1659	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1661	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1662	Focal Chorioretinitis and Focal Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1664	Focal Chorioretinitis and Focal Retinochoroiditis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1665	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2021-02	us	hl7